Renaissance Technologies - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$979
-18.1%
730,400
+9.4%
0.00%0.0%
Q2 2023$1,195
-58.2%
667,400
-9.3%
0.00%
-50.0%
Q1 2023$2,862
+344.4%
735,700
+288.6%
0.00%
+300.0%
Q4 2022$644
-100.0%
189,300
-38.6%
0.00%
-50.0%
Q3 2022$1,683,000
-17.9%
308,300
-32.2%
0.00%0.0%
Q2 2022$2,051,000
+29.4%
454,800
+111.4%
0.00%0.0%
Q1 2022$1,585,000
+187.1%
215,100
+150.4%
0.00%
+100.0%
Q4 2021$552,000
-80.9%
85,900
-82.7%
0.00%
-75.0%
Q3 2021$2,883,000
+1409.4%
495,400
+2581.9%
0.00%
Q2 2021$191,000
-94.5%
18,472
-89.8%
0.00%
-100.0%
Q2 2020$3,443,000
-66.4%
181,800
-66.0%
0.00%
-70.0%
Q1 2020$10,258,000
+233.4%
534,000
+232.7%
0.01%
+400.0%
Q4 2019$3,077,000
+599.3%
160,500
+118.3%
0.00%
Q2 2019$440,000
-91.8%
73,515
-92.0%
0.00%
-100.0%
Q1 2019$5,366,000
+34.4%
918,800
+115.6%
0.01%
+25.0%
Q4 2018$3,994,000
+231.7%
426,253
+502.9%
0.00%
+300.0%
Q3 2018$1,204,000
-48.6%
70,700
-48.7%
0.00%0.0%
Q2 2018$2,343,000137,9000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders